CONTRACEPTION

CONTRACEPTION
WHAT IS NEW
WHAT IS OLD
WHAT IS IMPROVED
ASSESSMENT
NUMBER OF PARTNERS
FREQUENCY OF COITUS
LEVEL OF CONTRACEPTIVE
INVOLVEMENT
PARTNER/CLIENT OBJECTIONS TO
CONTRACEPTIVE METHOD
BRAIDED
BBENEFITS
ADVANTAGES/RATE OF SUCCESS
RRISKS
AALTERNATIVES
IINQUIRIES
DDECUSUIBS
EEXPLANATION
D--DOCUMENTATION
IDEAL CONTRACTEPTION
SAFE
EASILY AVAILABLE
ECONOMICAL
ACCEPTABLE
SIMPLE TO USE
PROMPTLY REVERSIBLE.
CONTRACEPTIVE FAILURE
RATE OF ACCIDENTAL
PREGNANCY IN THE FIRST YEAR
EVEN WHEN THE METHOD HAS
BEEN USED CONSISTENLY AND
CORRECTLY.
FACTORS AFFECTING EFFECTIVENESS
FREQUENCY OF INTERCOURSE
MOTIVATION TO PREVENT
PREGNANCY
UNDERSTANDING OF HOW TO USE
METHOD
ADHERENCE TO METHOD
PROVISION OF LONG-
TERM/SHORT-TERM PROTECTION
LIKLIHOOD OR PREGNANCY FOR
INDIVIDUAL WOMAN
CONSISTANT USE OF METHOD
CONTRACEPTIVE METHODS
NATURAL
BARRIER
HORMONAL
IUD (IUS) INTRAUTERINE DEVICES
OR SYSTEMS
STERILIZATION
NATURAL
COITUS INTERRUPTUS
(WITHDRAWL)
NATURAL FAMILY PLANNING (NFP)
FERTILITY AWARENESS METHODS
CALENDAR
BBT
CERVICAL MUCUS
SYMPOTHERMAL
CYCLE BEADS (NEW)
CALENDER
IMPORTANT TO HAVE REGULAR
PERIODS
SHORTEST CYCLE
24-18 = 6
TH
DAY
LONGEST CYCLE
30-11 = 19
TH
DAY
ABSTAIN DAYS 6-19 OF CYCLE
BBT (BASAL BODY TEMPERATURE)
BBTLOWEST BODY
TEMPERATURE TAKEN
IMMEDIATELY AFTER WAKING AND
BEFORE GETTING OUT OF BED.
CERVICAL MUCUS-OVULATION DETECTION
RECOGNIZE AND INTREPRET
CHANGES IN MUCUS
CHARACTERTISTICS.
SPINNBARKHEIT
MUCUS CLEAR, WET SLIPPERY
SYMPOTHERMAL METHOD
COMBINES BBT AND CERVICAL
MUCUS METHODS
INCREASE LIBIDO, MIDCYCLE
SPOTTING OR PAIN
(MITTLESCHMERZ) PELVIC
FULLNESS OR TENDERNESS, OR
VULVAR FULLNESS
MAY BE SIGNALS OF OVULATION
CYCLE BEADS
NEWER METHOD OF FERTILITY
AWARENESS.
BASED ON MENSTRUAL CYCLES
OF 26-32 DAYS.
PREDICTORS OF OVULATION
HOME TESTS THAT DETERMINES
THE LH SURGE 12-24 HOURS
BEFORE OVULATION.
BARRIER METHODS
CONDOMSMALE AND FEMALE
SPERMICIDES
DIAPHRAGM
CERVICAL CAP
CONCERNS FOR TSS (TOXIC
SHOCK SYNDROME)
CONDOMS
MALE AND FEMALE TYPES
PRIMARILY LATEX BUT ARE USING
OTHER MATERIALS
AVOID USING WITH OIL BASED
LUBRICANTS
HAVE EXPIRATION DATE
NOT 100% EFFECTIVE AGAINST STI
OR HIV
SPERMICIDE
FAILURE RATE 29%
CONTINUED USE CAN INCREASE
RISK OF HIV, CHLAMYDIA/GC AND
GENITAL LESIONS.
NONOXYNOL-9
CAN INSERT 1 HOUR PRIOR TO
INTERCOURSE BUT MUST BE
REPEATED BEFORE EACH ACT.
DIAPHRAGM
FAILURE RATE 16%
CAN BE INSERTED PRIOR TO
INTERCOURSE
USE SPERMICIDE ALONG WITH
DIAPHRAGM
LEAVE IN PLACE FOR AT LEAST 6
HOURS AFTER LAST
INTERCOURSE
HAS TO BE FITTED BY PROVIDER
CERVICAL CAP
FITS AROUND BASE OF CERVIX
CAP TO REMAIN IN PLACE NO LESS
THAN 8 HOURS AND NO MORE
THAN 48 HOURS.
LEAVE IN AT LEAST 6 HOURS
AFTER LAST INTERCOURSE
USE WITH SPERMICIDE
FITTED BY PROVIDER
TSS (TOXIC SHOCK SYNDROME)
SMALL NUMBER OF OCCURANCES
WITH DIAPHRAGM OR CAP
DONT USE DURING MENSES
REMOVE 6-8 HR AFTER LAST
INTERCOURSE
S/STEMP GREATER THAN 38.4 C
SUDDEN ONSET OF HYPOTENSION
(90 MM HG SYSTOLIC)
ORTHOSTATIC DIZZINESS
RASH
CONTRACEPTIVE SPONGE
NOT CURRENTLY AVAILABLE IN
USA.
PRODUCTION ISSUES
AVAILABLE IN OTHER COUNTRIES
HORMONAL METHODS
COMBINATION ESTROGEN-
PROGESTIN CONTRACEPTIVE
(PILL)
INJECTABLE COMBINATION
TRANSDERMAL SYSTEM
VAGINAL RING
PROGESTIN ONLY PILLS
INJECTABLE PROGESTIN
IMPLANTABLE PROGESTIN
EC (EMERGENCY
CONTRACEPTION)
COCCOMBINATION E/P PILLS
USUALLY 21 DAYS ACTIVE PILLS
WITH 7 DAYS INACTIVE PILLS
EXTENDED USE PILLS
OTHER USE FOR COC BESIDES
CONTRACEPTION
DOES NOT ACT AS ABORTIFACANT
DOES NOT PROTECT AGAINST STI
AND HIV
INJECTABLE COMBINED E/P
LUNELLEMONTHLY INJECTION
EVERY 28 DAYS +/- 5 DAYS
NOT CURRENTLY AVAILABLE
BECAUSE OF QA ISSUES
TRANSDERMAL SYSTEM
APPLY WEEKLY FOR 3 WEEKS,
REMOVE FOR 1 WEEK.
AVOIDS FIRST PASS EFFECT.
APPLY TO LOWER ABDOMEN,
UPPER OUTER ARM, BUTTOCKS,
OR UPPER TORSO BUT NOT
BREAST AREA.
ORTHO EVRA
NEEDS PROVIDER TO PRESCRIBE
VAGINAL RING
NUVARING
INSERT FOR 3 WEEKS
REMOVE FOR 1 WEEK
DOESNT HAVE TO BE FITTED
NEEDS PROVIDER TO PRESCRIBE
ACHES
AABDOMINAL PAIN
CCHEST PAIN, SOB
HHEADACHE CHANGES
EEYE PROBLEMS
SSEVERE LEG PAIN
WARNINGS FOR COC USERS
PROGESTIN ONLY PILLS
MICRONORMINI PILL
INHIBITS OVULATION
THICKS CERVICAL MUCUS
SLOWS CILIA ACTION IN TUBES
DAILY USE
CAN USE WITH BREASTFEEDING
INJECTABLE PROGESTIN
DMPADEPO PROVERA
IM INJECTION EVERY 12 WEEKS
(11-13 WEEKS)
DONT MASSAGE INJECTION SITE
AS INTERFERS WITH ABSORPTION
CAN ALTER BLOOD GLUCOSE
IRREGULAR BLEEDING OR
AMENORRHEA
RETURN TO FERTILITY CAN BE
DELAYED

IMPLANTABLE PROGESTINS

NORPLANT6 CAPSULE SYSTEM 5
YEAR COVERAGE
NO LONGER AVAILABLE IN USA
COMING OUT WITH 1 ROD SYSTEM
IN NEXT YEAR OR TWO
EMERGENCY CONTRACEPTION
PLAN B
USE WHEN UNPROTECTED
INTERCOURSE HAS OCCURRED
AND WITHIN 72 HOURS.
NOT AN ABORTIFACANT
INCREASED DOSES OF COC
INCREASE OF NAUSEA, VOMITING
CONTRAVERSIALSOME
PHARMACIES WILL NOT FILL RX
IUD/IUS INTERUTERINE DEVICE/SYSTEM
COPPER T380A10 YEARS
MIRENA5 YEARS
LONG TERM METHOD REVERSIBLE
PROVIDER MUST INSERT/REMOVE
MAY HAVE IRREGULAR BLEEDING
NEED TO CHECK FOR STRING
PLACEMENT AFTER EACH MENSES
PAINS
PPERIOD LATE, ABNORMAL
BLEEDING
AABDOMINAL PAIN
IINFECTION EXPOSURE
NNOT FEELING WELL
SSTRINGS MISSING, SHORTER
OR LONGER
STERILIZATION
SURGICAL PROCEDURE INTENDED
TO RENDER A PERSON STERILE
ARE PERFORMED AFTER
DELIVERY
FEMALE, FEDERAL FUNDING
CLIENT AT LEAST 21 YRS OLD AND
A 30 DAY WAITING PERIOD
MALENOT IMMEDIATE STERILITY
INFORMED CONSENT
SPOUSAL CONSENT IS NOT
REQUIRED BUT IMPORTANT THAT
BOTH ARE IN AGREEMENT.
CANNOT STERILIZE MINORS OR
MENTALLY INCOMPETENT
EXPLANATION OF RISKS/BENEFITS
MUST HAVE TRANSLATOR OR
CONSENT IN CLIENTS LANGUAGE,
IF NOT ENGLISH SPEAKING
ABORTION
INDUCED ABORTION BEFORE 20
WEEKS GESTATION.
ELECTIVE
THERAPEUTIC
PRESERVATION OF THE LIFE OR
HEALTH OF MOTHER
GENETIC DISORDERS OF FETUS
RAPE OR INCEST
PREGNANT WOMANS REQUEST

FIRST TRIMESTER ABORTION
VACUUM ASPIRATIONMOST
COMMON
MIFEPRISTONE (RU486)
PROSTAGLANDIN AGENT
METHOTREXATE-MISOPROSTOL
SECOND TRIMESTER ABORTION
DILATION AND EVACUATION (D&E)
PROSTAGLANDINS
HYPERTONIC/UTEROTONIC
AGENTS